Process View
The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP (cAMP).

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "adenylate cyclase inhibiting adrenergic receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MPDZ | multiple PDZ domain protein | 1.000 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 1.000 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 1.000 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 1.000 | ||
| ARRDC3 | arrestin domain containing 3 | 0.938 | ||
| PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0.928 | ||
| PTEN | phosphatase and tensin homolog | 0.695 | ||
| SSTR3 | somatostatin receptor 3 | 0.689 | ||
| BAI1 | brain-specific angiogenesis inhibitor 1 | 0.345 | ||
| GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.252 | ||
| HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A | 0.238 | Human | |
| DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.177 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.174 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.169 | Human | |
| GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 0.160 | ||
| HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.157 | Human | |
| TSHR | thyroid stimulating hormone receptor | 0.138 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.120 | Human | |
| RELN | reelin | 0.099 | ||
| GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | 0.088 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.087 | ||
| RIMS4 | regulating synaptic membrane exocytosis 4 | 0.087 | ||
| AQP7 | aquaporin 7 | 0.076 | ||
| PLEKHA2 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 | 0.075 | ||
| CEACAM4 | carcinoembryonic antigen-related cell adhesion molecule 4 | 0.070 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.063 | ||
| DSCAML1 | Down syndrome cell adhesion molecule like 1 | 0.059 | ||
| GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.058 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.056 | ||
| HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D | 0.056 | Human | |
| YAP1 | Yes-associated protein 1 | 0.052 | ||
| GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.051 | ||
| ZP2 | zona pellucida glycoprotein 2 (sperm receptor) | 0.051 | ||
| GRM5 | glutamate receptor, metabotropic 5 | 0.051 | ||
| COPG2 | coatomer protein complex, subunit gamma 2 | 0.048 | ||
| ADRA2B | adrenergic, alpha-2B-, receptor | 0.047 | ||
| PLA2G1B | phospholipase A2, group IB (pancreas) | 0.047 | ||
| DPP6 | dipeptidyl-peptidase 6 | 0.046 | ||
| CHRNB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | 0.046 | ||
| HTR7 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | 0.045 | ||
| NTSR1 | neurotensin receptor 1 (high affinity) | 0.045 | ||
| GHRHR | growth hormone releasing hormone receptor | 0.044 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.044 | Human | |
| GPR6 | G protein-coupled receptor 6 | 0.043 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.042 | ||
| USP33 | ubiquitin specific peptidase 33 | 0.042 | ||
| CCK | cholecystokinin | 0.042 | ||
| KCNJ1 | potassium inwardly-rectifying channel, subfamily J, member 1 | 0.041 | ||
| CRP | C-reactive protein, pentraxin-related | 0.041 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.040 | Human | |
| PAX6 | paired box 6 | 0.039 | ||
| SPRR2A | small proline-rich protein 2A | 0.039 | ||
| DRD1 | dopamine receptor D1 | 0.038 | Human | |
| HRH3 | histamine receptor H3 | 0.038 | ||
| HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A | 0.038 | ||
| GHRH | growth hormone releasing hormone | 0.038 | ||
| AFF2 | AF4/FMR2 family, member 2 | 0.036 | ||
| TBR1 | T-box, brain, 1 | 0.036 | ||
| ADRA1A | adrenergic, alpha-1A-, receptor | 0.036 | ||
| CHRNB4 | cholinergic receptor, nicotinic, beta 4 | 0.036 | ||
| SCN1B | sodium channel, voltage-gated, type I, beta | 0.035 | ||
| ACHE | acetylcholinesterase | 0.035 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.035 | ||
| CALY | calcyon neuron-specific vesicular protein | 0.034 | ||
| PADI4 | peptidyl arginine deiminase, type IV | 0.034 | ||
| TBX5 | T-box 5 | 0.034 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.034 | ||
| CDK5R2 | cyclin-dependent kinase 5, regulatory subunit 2 (p39) | 0.033 | ||
| GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 0.033 | ||
| ODF1 | outer dense fiber of sperm tails 1 | 0.033 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.033 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.032 | ||
| GRIA2 | glutamate receptor, ionotropic, AMPA 2 | 0.032 | ||
| CALCR | calcitonin receptor | 0.031 | ||
| VIPR2 | vasoactive intestinal peptide receptor 2 | 0.030 | ||
| ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 0.030 | ||
| CACNA1H | calcium channel, voltage-dependent, T type, alpha 1H subunit | 0.030 | ||
| KCNJ6 | potassium inwardly-rectifying channel, subfamily J, member 6 | 0.030 | ||
| NELL1 | NEL-like 1 (chicken) | 0.029 | ||
| PSG7 | pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) | 0.029 | ||
| KCNE1 | potassium voltage-gated channel, Isk-related family, member 1 | 0.029 | ||
| NRCAM | neuronal cell adhesion molecule | 0.029 | ||
| OMP | olfactory marker protein | 0.029 | ||
| CCKBR | cholecystokinin B receptor | 0.029 | ||
| LILRA4 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 | 0.028 | ||
| CDH8 | cadherin 8, type 2 | 0.028 | ||
| KRT33B | keratin 33B | 0.027 | ||
| LGI1 | leucine-rich, glioma inactivated 1 | 0.027 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.027 | ||
| GP5 | glycoprotein V (platelet) | 0.027 | ||
| TRH | thyrotropin-releasing hormone | 0.027 | ||
| GDF10 | growth differentiation factor 10 | 0.026 | ||
| KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 0.026 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.026 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.025 | ||
| NEUROG3 | neurogenin 3 | 0.025 | ||
| SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | 0.025 | ||
| SLC6A1 | solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | 0.025 | ||
| OPCML | opioid binding protein/cell adhesion molecule-like | 0.025 | ||
| LEP | leptin | 0.025 | ||
| CNNM1 | cyclin M1 | 0.025 | ||
| PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | 0.024 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.024 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.024 | ||
| TNP2 | transition protein 2 (during histone to protamine replacement) | 0.024 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.024 | ||
| MUSK | muscle, skeletal, receptor tyrosine kinase | 0.023 | ||
| NPPA | natriuretic peptide A | 0.023 | ||
| MUC1 | mucin 1, cell surface associated | 0.023 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.023 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.023 | ||
| ALX1 | ALX homeobox 1 | 0.023 | ||
| SEMA3D | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D | 0.022 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.022 | ||
| NPY1R | neuropeptide Y receptor Y1 | 0.022 | ||
| MYF6 | myogenic factor 6 (herculin) | 0.022 | ||
| UNC13A | unc-13 homolog A (C. elegans) | 0.022 | ||
| IL6R | interleukin 6 receptor | 0.021 | ||
| ADAM2 | ADAM metallopeptidase domain 2 | 0.021 | ||
| FOXD3 | forkhead box D3 | 0.021 | ||
| NXPH3 | neurexophilin 3 | 0.021 | ||
| P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 | 0.021 | ||
| SIX3 | SIX homeobox 3 | 0.021 | ||
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.021 | ||
| PDYN | prodynorphin | 0.021 | ||
| DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0.021 | ||
| GPR101 | G protein-coupled receptor 101 | 0.021 | ||
| SCN2B | sodium channel, voltage-gated, type II, beta | 0.021 | ||
| THPO | thrombopoietin | 0.020 | ||
| NKX2-1 | NK2 homeobox 1 | 0.020 | ||
| TREH | trehalase (brush-border membrane glycoprotein) | 0.020 | ||
| CLCN1 | chloride channel 1, skeletal muscle | 0.020 | ||
| GFRA1 | GDNF family receptor alpha 1 | 0.020 | ||
| RAI2 | retinoic acid induced 2 | 0.020 | ||
| SLC6A11 | solute carrier family 6 (neurotransmitter transporter, GABA), member 11 | 0.020 | ||
| SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 0.020 | ||
| SMR3A | submaxillary gland androgen regulated protein 3A | 0.020 | ||
| OCA2 | oculocutaneous albinism II | 0.020 | ||
| GUCY1A2 | guanylate cyclase 1, soluble, alpha 2 | 0.020 | ||
| GJA5 | gap junction protein, alpha 5, 40kDa | 0.020 | ||
| DGKQ | diacylglycerol kinase, theta 110kDa | 0.019 | ||
| P2RX3 | purinergic receptor P2X, ligand-gated ion channel, 3 | 0.019 | ||
| HOXC11 | homeobox C11 | 0.019 | ||
| PNMT | phenylethanolamine N-methyltransferase | 0.019 | ||
| SLC6A7 | solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 | 0.019 | ||
| FGF20 | fibroblast growth factor 20 | 0.019 | ||
| GUCY2C | guanylate cyclase 2C (heat stable enterotoxin receptor) | 0.019 | ||
| TEF | thyrotrophic embryonic factor | 0.018 | ||
| GFRA2 | GDNF family receptor alpha 2 | 0.018 | ||
| GIF | gastric intrinsic factor (vitamin B synthesis) | 0.018 | ||
| BPIL3 | bactericidal/permeability-increasing protein-like 3 | 0.018 | ||
| ACCN1 | amiloride-sensitive cation channel 1, neuronal | 0.018 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.018 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.018 | ||
| ADRB1 | adrenergic, beta-1-, receptor | 0.018 | Human | |
| GPC5 | glypican 5 | 0.018 | ||
| TG | thyroglobulin | 0.018 | ||
| CDKL1 | cyclin-dependent kinase-like 1 (CDC2-related kinase) | 0.018 | ||
| SLC22A2 | solute carrier family 22 (organic cation transporter), member 2 | 0.018 | ||
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.018 | ||
| FGF6 | fibroblast growth factor 6 | 0.017 | ||
| MTMR7 | myotubularin related protein 7 | 0.017 | ||
| GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | 0.017 | ||
| NOVA2 | neuro-oncological ventral antigen 2 | 0.017 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.017 | ||
| APOC3 | apolipoprotein C-III | 0.017 | ||
| SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 0.017 | ||
| LPAR4 | lysophosphatidic acid receptor 4 | 0.017 | ||
| TFF2 | trefoil factor 2 | 0.017 | ||
| ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | 0.017 | ||
| TLX3 | T-cell leukemia homeobox 3 | 0.017 | ||
| KCNB1 | potassium voltage-gated channel, Shab-related subfamily, member 1 | 0.017 | ||
| MYL3 | myosin, light chain 3, alkali; ventricular, skeletal, slow | 0.017 | ||
| SCTR | secretin receptor | 0.017 | ||
| MAG | myelin associated glycoprotein | 0.017 | ||
| OMD | osteomodulin | 0.017 | ||
| OPRK1 | opioid receptor, kappa 1 | 0.017 | ||
| HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A | 0.017 | Human | |
| CACNG3 | calcium channel, voltage-dependent, gamma subunit 3 | 0.016 | ||
| KCNC4 | potassium voltage-gated channel, Shaw-related subfamily, member 4 | 0.016 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.016 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.016 | ||
| FGF17 | fibroblast growth factor 17 | 0.016 | ||
| AMOT | angiomotin | 0.016 | ||
| KL | klotho | 0.016 | ||
| OPRL1 | opiate receptor-like 1 | 0.016 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.016 | ||
| GRIK1 | glutamate receptor, ionotropic, kainate 1 | 0.016 | ||
| SLC18A1 | solute carrier family 18 (vesicular monoamine), member 1 | 0.016 | ||
| DOC2B | double C2-like domains, beta | 0.016 | ||
| KCNE1L | KCNE1-like | 0.016 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.016 | ||
| SEMA6B | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B | 0.016 | ||
| RHO | rhodopsin | 0.016 | ||
| BFSP1 | beaded filament structural protein 1, filensin | 0.016 | ||
| CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 0.016 | ||
| MYH6 | myosin, heavy chain 6, cardiac muscle, alpha | 0.015 | ||
| HMP19 | HMP19 protein | 0.015 | ||
| CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) | 0.015 | ||
| PRDM8 | PR domain containing 8 | 0.015 | ||
| ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 0.015 | ||
| CRYBB1 | crystallin, beta B1 | 0.015 | ||
| LNX1 | ligand of numb-protein X 1 | 0.015 | ||
| STX1A | syntaxin 1A (brain) | 0.015 | ||
| FGF18 | fibroblast growth factor 18 | 0.015 | ||
| ASB4 | ankyrin repeat and SOCS box containing 4 | 0.015 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.015 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.015 | ||
| ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 0.015 | ||
| GATA5 | GATA binding protein 5 | 0.015 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.015 | ||
| C3orf27 | chromosome 3 open reading frame 27 | 0.015 | ||
| CPLX2 | complexin 2 | 0.015 | ||
| SPTB | spectrin, beta, erythrocytic | 0.015 | ||
| SOX17 | SRY (sex determining region Y)-box 17 | 0.015 | ||
| CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 | 0.015 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.014 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.014 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.014 | ||
| ADRA1D | adrenergic, alpha-1D-, receptor | 0.014 | ||
| TNNI1 | troponin I type 1 (skeletal, slow) | 0.014 | ||
| KCNK15 | potassium channel, subfamily K, member 15 | 0.014 | ||
| HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A | 0.014 | Human | |
| PRG4 | proteoglycan 4 | 0.014 | ||
| AVPR1B | arginine vasopressin receptor 1B | 0.014 | ||
| CTRC | chymotrypsin C (caldecrin) | 0.014 | ||
| GH2 | growth hormone 2 | 0.014 | ||
| NEURL | neuralized homolog (Drosophila) | 0.014 | ||
| SCN7A | sodium channel, voltage-gated, type VII, alpha | 0.014 | ||
| REG1A | regenerating islet-derived 1 alpha | 0.014 | ||
| ZNF132 | zinc finger protein 132 | 0.014 | ||
| CHRND | cholinergic receptor, nicotinic, delta | 0.014 | ||
| PVALB | parvalbumin | 0.014 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.014 | ||
| CNN1 | calponin 1, basic, smooth muscle | 0.014 | ||
| KRT9 | keratin 9 | 0.014 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.014 | ||
| OR2H1 | olfactory receptor, family 2, subfamily H, member 1 | 0.014 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.014 | ||
| WNT8B | wingless-type MMTV integration site family, member 8B | 0.013 | ||
| CHIA | chitinase, acidic | 0.013 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.013 | ||
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.013 | ||
| PTH | parathyroid hormone | 0.013 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.013 | ||
| SCNN1G | sodium channel, nonvoltage-gated 1, gamma | 0.013 | ||
| AQP2 | aquaporin 2 (collecting duct) | 0.013 | ||
| GPR37L1 | G protein-coupled receptor 37 like 1 | 0.013 | ||
| FEZF2 | FEZ family zinc finger 2 | 0.013 | ||
| LHCGR | luteinizing hormone/choriogonadotropin receptor | 0.013 | ||
| RASL10A | RAS-like, family 10, member A | 0.013 | ||
| NPY5R | neuropeptide Y receptor Y5 | 0.013 | ||
| SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 0.013 | ||
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.013 | ||
| SSTR1 | somatostatin receptor 1 | 0.013 | ||
| PYY | peptide YY | 0.013 | ||
| LSAMP | limbic system-associated membrane protein | 0.013 | ||
| CRISP3 | cysteine-rich secretory protein 3 | 0.013 | ||
| EDDM3A | epididymal protein 3A | 0.013 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.012 | ||
| CAMK1G | calcium/calmodulin-dependent protein kinase IG | 0.012 | ||
| SOX14 | SRY (sex determining region Y)-box 14 | 0.012 | ||
| AANAT | aralkylamine N-acetyltransferase | 0.012 | ||
| CASR | calcium-sensing receptor | 0.012 | ||
| SCN2A | sodium channel, voltage-gated, type II, alpha subunit | 0.012 | ||
| SORCS3 | sortilin-related VPS10 domain containing receptor 3 | 0.012 | ||
| NPY2R | neuropeptide Y receptor Y2 | 0.012 | ||
| CDX4 | caudal type homeobox 4 | 0.012 | ||
| PRPH | peripherin | 0.012 | ||
| PTPRU | protein tyrosine phosphatase, receptor type, U | 0.012 | ||
| CNKSR2 | connector enhancer of kinase suppressor of Ras 2 | 0.012 | ||
| NOS2 | nitric oxide synthase 2, inducible | 0.012 | ||
| BOK | BCL2-related ovarian killer | 0.012 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.012 | ||
| FOXI1 | forkhead box I1 | 0.012 | ||
| FOXF2 | forkhead box F2 | 0.012 | ||
| GPR143 | G protein-coupled receptor 143 | 0.012 | ||
| ASGR1 | asialoglycoprotein receptor 1 | 0.012 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.012 | ||
| GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 | 0.012 | ||
| AKAP4 | A kinase (PRKA) anchor protein 4 | 0.012 | ||
| LRRN2 | leucine rich repeat neuronal 2 | 0.012 | ||
| HNF1B | HNF1 homeobox B | 0.012 | ||
| KCNH1 | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 0.012 | ||
| P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 | 0.012 | ||
| INA | internexin neuronal intermediate filament protein, alpha | 0.012 | ||
| PDE6H | phosphodiesterase 6H, cGMP-specific, cone, gamma | 0.012 | ||
| TACR2 | tachykinin receptor 2 | 0.012 | ||
| GYPA | glycophorin A (MNS blood group) | 0.012 | ||
| GRIK4 | glutamate receptor, ionotropic, kainate 4 | 0.012 | ||
| PDE3A | phosphodiesterase 3A, cGMP-inhibited | 0.012 | ||
| UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 0.012 | ||
| DDO | D-aspartate oxidase | 0.012 | ||
| HBE1 | hemoglobin, epsilon 1 | 0.012 | ||
| GPR27 | G protein-coupled receptor 27 | 0.012 | ||
| PENK | proenkephalin | 0.012 | ||
| CA10 | carbonic anhydrase X | 0.012 | ||
| GCM1 | glial cells missing homolog 1 (Drosophila) | 0.011 | ||
| ELAVL2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) | 0.011 | ||
| MYO1A | myosin IA | 0.011 | ||
| PAX8 | paired box 8 | 0.011 | ||
| TACR1 | tachykinin receptor 1 | 0.011 | ||
| PRKCG | protein kinase C, gamma | 0.011 | ||
| CADM3 | cell adhesion molecule 3 | 0.011 | ||
| KCNJ3 | potassium inwardly-rectifying channel, subfamily J, member 3 | 0.011 | ||
| FOXN1 | forkhead box N1 | 0.011 | ||
| CORIN | corin, serine peptidase | 0.011 | ||
| CNTN2 | contactin 2 (axonal) | 0.011 | ||
| STMN2 | stathmin-like 2 | 0.011 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.011 | ||
| PGM5 | phosphoglucomutase 5 | 0.011 | ||
| HOXD10 | homeobox D10 | 0.011 | ||
| GDF5 | growth differentiation factor 5 | 0.011 | ||
| RYR3 | ryanodine receptor 3 | 0.011 | ||
| SMR3B | submaxillary gland androgen regulated protein 3B | 0.011 | ||
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.011 | ||
| PRM2 | protamine 2 | 0.011 | ||
| CDX2 | caudal type homeobox 2 | 0.011 | ||
| PCDH8 | protocadherin 8 | 0.011 | ||
| ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | 0.011 | ||
| DSPP | dentin sialophosphoprotein | 0.011 | ||
| PKNOX2 | PBX/knotted 1 homeobox 2 | 0.011 | ||
| STAR | steroidogenic acute regulatory protein | 0.011 | ||
| RCAN2 | regulator of calcineurin 2 | 0.011 | ||
| PLA2G5 | phospholipase A2, group V | 0.011 | ||
| IL5RA | interleukin 5 receptor, alpha | 0.011 | ||
| HSD17B3 | hydroxysteroid (17-beta) dehydrogenase 3 | 0.011 | ||
| BFSP2 | beaded filament structural protein 2, phakinin | 0.011 | ||
| GABRG3 | gamma-aminobutyric acid (GABA) A receptor, gamma 3 | 0.011 | ||
| GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 0.011 | ||
| CNGA3 | cyclic nucleotide gated channel alpha 3 | 0.011 | ||
| GYPE | glycophorin E (MNS blood group) | 0.011 | ||
| TMSB4Y | thymosin beta 4, Y-linked | 0.011 | ||
| MAGI1 | membrane associated guanylate kinase, WW and PDZ domain containing 1 | 0.011 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.011 | ||
| SGCA | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | 0.011 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.011 | ||
| CDH22 | cadherin 22, type 2 | 0.011 | ||
| TYRP1 | tyrosinase-related protein 1 | 0.011 | ||
| CHRNB3 | cholinergic receptor, nicotinic, beta 3 | 0.011 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.011 | ||
| GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 | 0.011 | ||
| RHOU | ras homolog gene family, member U | 0.011 | ||
| MYOD1 | myogenic differentiation 1 | 0.011 | ||
| CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 | 0.011 | ||
| CACNA1D | calcium channel, voltage-dependent, L type, alpha 1D subunit | 0.011 | ||
| TNNI3 | troponin I type 3 (cardiac) | 0.011 | ||
| CRYGC | crystallin, gamma C | 0.011 | ||
| GAP43 | growth associated protein 43 | 0.011 | ||
| FSCN2 | fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) | 0.010 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.010 | ||
| GPR1 | G protein-coupled receptor 1 | 0.010 | ||
| GCG | glucagon | 0.010 | ||
| SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 0.010 | ||
| RIMS1 | regulating synaptic membrane exocytosis 1 | 0.010 | ||
| PAX3 | paired box 3 | 0.010 | ||
| PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.010 | ||
| GRIK3 | glutamate receptor, ionotropic, kainate 3 | 0.010 | ||
| F2RL2 | coagulation factor II (thrombin) receptor-like 2 | 0.010 | ||
| ST8SIA5 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 | 0.010 | ||
| CNTFR | ciliary neurotrophic factor receptor | 0.010 | ||
| HBZ | hemoglobin, zeta | 0.010 | ||
| TRPC6 | transient receptor potential cation channel, subfamily C, member 6 | 0.010 | ||
| SCGB1A1 | secretoglobin, family 1A, member 1 (uteroglobin) | 0.010 | ||
| EFNB3 | ephrin-B3 | 0.010 | ||
| TGM5 | transglutaminase 5 | 0.010 | ||
| PCSK2 | proprotein convertase subtilisin/kexin type 2 | 0.010 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.010 | ||
| COLQ | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | 0.010 | ||
| UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 0.010 | ||
| GNGT1 | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 | 0.010 |